Emulate Therapeutics Revenue, Growth & Competitor Profile

DBA NATIVIS

Company Profile & Annual Report for Emulate Therapeutics

Access the complete profile.

Emulate Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	54171 Research & Development in the Physical, Engineering & Life Sciences
Address	13810 Se Eastgate Way Ste 560 Bellevue, WA 98005

Note: Revenues for privately held companies are statistical evaluations.


Emulate Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Emulate Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Emulate Therapeutics is classified as operating in the Research & Development in the Physical, Engineering & Life Sciences industry, NAICS Code 54171.

Emulate Therapeutics Annual Revenue and Growth Rate

Emulate Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Emulate Therapeutics's revenues are gauged from an analysis of company filings.

Emulate Therapeutics's Income Statement (based on Industry Averages)

Emulate Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Emulate Therapeutics is developing and marketing. Emulate Therapeutics doesn't have any recent trademark applications, indicating Emulate Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
HÆLO Medical apparatus for use in treating cancer and solid cancer tumors ; Medical device for treating cancer	04/29/2022
EMULATE Pharmaceutical, chemical and biotechnology products, namely, diagnostic and bioactivation preparations and chemical reagents for clinical or medical laboratory use; clinical medical reagents; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for medical use; biological and chemical preparations for medical use for the treatment for cancer, heart disease, and neurological diseases and medical diagnostic reagents; biological preparations for medical purposes for the treatment of cancer, heart disease, and neurological diseases; aqueous solutions and signals in the nature of diagnostic or therapeutic preparations for medical purposes; biochemicals, namely, antibodies, nucleosides, nucleotides, interferons, solvents, solutions, enzymes, proteins, nucleic acids for medical use	03/01/2019
EMULATE THERAPEUTICS Pharmaceutical, chemical and biotechnology products, namely, diagnostic and bioactivation preparations and chemical reagents for clinical or medical laboratory use; clinical medical reagents; diagnostic preparations for clinical or medical laboratory use; diagnostic reagents for medical use; biological and chemical preparations for medical use for the treatment for cancer, heart disease, and neurological diseases and medical diagnostic reagents; biological preparations for medical purposes for the treatment of cancer, heart disease, and neurological diseases; aqueous solutions and signals in the nature of diagnostic or therapeutic preparations for medical purposes; biochemicals, namely, antibodies, nucleosides, nucleotides, interferons, solvents, solutions, enzymes, proteins, nucleic acids for medical use	03/01/2019

See all trademarks and details in the Full Report.

Market Share of Emulate Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Emulate Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
AXIOM SPACE	Houston, TX	1
ADVANCED CLINICAL HOLDINGS	Deerfield, IL	1
PONCE MEDICAL SCHOOL FOUNDATION	Ponce, PR	1
MARSHALL UNIVERSITY	Huntington, WV	1
RESEARCH INNOVATIONS	Alexandria, VA	1
VOYAGER SPACE HOLDINGS	Denver, CO	1
DEEP NORTH	Redwood City, CA	0
EPIRUS	Hawthorne, CA	0

Nearby Competitors

These companies are similar in business line and location to Emulate Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
EXPLORE VENTURES	Kent, WA	100
SEAGEN	Bothell, WA	82
STEMCELL TECHNOLOGIES	Kent, WA	6
INVENTPRISE	Redmond, WA	4
VIOME LIFE SCIENCES	Bellevue, WA	3
GLOBAL HEALTH LABS	Kirkland, WA	3

Future Competition: Emulate Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Emulate Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)